POMC is not a single-purpose hormone. It is a cleavable precursor system: one genetic and molecular source that can be processed into distinct regulatory peptides depending on tissue, enzyme context, and physiological demand. In the Metastrophe framework, POMC is the biological grammar behind three regulatory fuels — ACTH for mobilization, β-endorphin for conservation, and α-MSH / melanocortin signaling for recalibration.
The peptides below are its major regulatory outputs in this model: ACTH for mobilization, β-endorphin for conservation, and α-MSH / melanocortin signaling for recalibration.
Stress economy, cortisol release, glucose availability, cardiovascular activation, and action under pressure.
Open ACTH →Opioid economy, analgesia, endurance, protective withdrawal, shielding, and conservation under overwhelming demand.
Open β-Endorphin →Melanocortin signaling across immune precision, appetite, inflammation, repair, metabolic balance, and approach.
Open α-MSH →This hub keeps POMC at the parent level: a cleavable precursor grammar whose outputs map onto the three regulatory fuels of the affective sphere.
Click any box to jump to the full explanation below.
POMC is the parent page for the peptide-family resource. The sections below explain how one precursor can generate multiple regulatory fuels without collapsing them into one undifferentiated stress signal.
Proopiomelanocortin, or POMC, is a prohormone precursor. It is synthesized as a larger polypeptide and then cleaved by processing enzymes into smaller peptides with distinct biological functions. The same parent molecule can yield ACTH, melanocortin peptides such as α-MSH, β-lipotropin fragments, and β-endorphin, depending on where and how it is processed.
That is why POMC is an ideal entry point into affective regulation. It is not simply “stress hormone” biology and not simply “opioid” biology. It is a coordinated precursor architecture that distributes different regulatory products across different tissues and contexts.
A single precursor does not mean a single message. POMC allows the organism to generate different messages from one molecular source. Tissue-specific processing determines whether the dominant output is ACTH, α-MSH, β-endorphin, or a combination of intermediate and mature peptides.
POMC expression is distributed: the same gene can support endocrine, neural, and local tissue regulation.
POMC was first characterized through pituitary ACTH biology, but it is not limited to the pituitary. It is highly expressed in anterior pituitary corticotrophs and in hypothalamic POMC neurons, and it is also produced locally in peripheral tissues including skin and immune-related compartments.
Local POMC expression means the body does not always wait for a central endocrine signal. Skin, immune, and neural tissues can generate POMC-derived signals close to the site where regulation is needed. This allows the same precursor family to operate both as long-range endocrine broadcast and as local paracrine or autocrine regulation.
Because POMC is expressed in central, endocrine, and peripheral contexts, it is well positioned to coordinate organism-wide state while still permitting tissue-specific responses. The same family can participate in stress output, energy balance, pigmentation, inflammation, pain modulation, and behavior.
Processing enzymes and tissue context determine which POMC-derived peptides dominate.
POMC contains cleavage sites, often paired basic amino acid residues, that are recognized by prohormone convertases. PC1/3 and PC2 are especially important. Different tissues express different processing enzymes, which is why the same precursor can yield different peptide profiles.
In anterior pituitary corticotrophs, POMC processing is dominated by ACTH and β-lipotropin output. In hypothalamic neurons and in the intermediate lobe of species that retain it prominently, processing is more extensive: ACTH can be further processed toward α-MSH and CLIP, while β-lipotropin can be processed toward β-endorphin.
POMC is therefore not best understood as one substance with one function. It is a conditional processing architecture. The organism can preserve a shared precursor while diversifying outputs according to tissue, developmental state, and physiological demand.
Biologically, POMC-derived peptides participate in stress, energy balance, appetite, pain modulation, pigmentation, immune regulation, inflammation, and behavior. The Metastrophe model reads those outputs as a coordinated regulatory dispatch: what state is the organism in, what mode of response is demanded, and does the organism have the budget to meet that demand?
The coordinate system is not a standard biochemical claim. It is the theoretical interpretation that links POMC biology to affective geometry. The standard biology establishes that POMC is a precursor system with multiple tissue-specific outputs. The model proposes that those outputs can be organized functionally as regulatory fuels.
ACTH links POMC processing to the HPA axis and organismic mobilization.
ACTH is the POMC-derived peptide most directly associated with endocrine stress mobilization. In the HPA axis, hypothalamic CRH stimulates anterior pituitary corticotrophs, which process POMC and release ACTH. ACTH then acts on the adrenal cortex to stimulate glucocorticoid production, especially cortisol in humans.
Mobilization requires spendable capacity: glucose availability, cardiovascular readiness, immune and metabolic reprioritization, and the ability to act under pressure. In this model, ACTH marks the mobilizing economy that makes direct action possible when the organism has enough supply to meet the demand.
When mobilization is demanded but ACTH / downstream stress economy is insufficient, the organism may still activate but cannot effectively neutralize threat. That mismatch is what the sphere labels anxiety. When mobilization has enough supply, the system can move toward the threat; that is the architecture behind anger and attack.
β-endorphin is produced from the C-terminal region of POMC through processing of β-lipotropin. Its biological identity is opioid: it binds opioid receptors and participates in analgesia, reward, stress adaptation, and endurance.
Conservation is not merely absence of action. It is an active regulatory mode that lowers expenditure and protects the organism when action is impossible, too costly, or dangerous. β-endorphin is therefore treated here as a conservation fuel: it supports pain reduction, withdrawal, endurance, and protective distancing from intolerable demand.
When conservation is demanded and β-endorphin supply is sufficient, shutdown can function as a shield: the organism reduces pain and survives what cannot be changed. When conservation is demanded but opioid supply is insufficient, the system shuts down without adequate protection. That mismatch is the architecture behind depression in the threat face of the sphere.
α-MSH is derived from the ACTH region of POMC through further processing. This matters conceptually: recalibration does not replace mobilization from the outside. It is latent within the same precursor architecture, becoming available when processing context allows the mobilizing signal to be refined into melanocortin regulation.
ACTH and β-endorphin are familiar enough to many clinicians as stress and opioid systems. α-MSH is less familiar, yet it is the crucial hinge of this model. It is involved in pigmentation, appetite suppression, energy balance, immune modulation, anti-inflammatory signaling, thermoregulation, CNS behavior, sexual desire, neuroprotection, cardiovascular protection, and skin repair.
In the Metastrophe framework, α-MSH is the recalibrative fuel: the peptide economy that helps the organism update state, restore balance, modulate inflammation precisely, and reopen approach after chronic demand. It is not merely a libido signal or pigmentation hormone; it belongs to the broader melanocortin system of repair, appetite, inflammation, and behavioral approach.
Hypothalamic POMC neurons, especially in the arcuate nucleus, are central to energy balance. They respond to signals such as leptin and insulin, release melanocortin peptides, and project to downstream sites where MC3R and MC4R signaling influences appetite, satiety, and energy expenditure.
POMC neurons are opposed by AgRP / NPY neurons. AgRP acts as an endogenous antagonist or inverse agonist at melanocortin receptors, especially MC4R. This creates a regulatory opposition between satiety / expenditure signaling and hunger / energy acquisition signaling.
Human POMC or melanocortin-pathway defects can produce severe early-onset obesity, impaired satiety, adrenal insufficiency, and pigmentation changes, depending on where the pathway is disrupted. This makes the POMC system an unusually clear example of a molecular architecture linking metabolism, stress response, and behavior.
The important claim is not that POMC invented peptide signaling. Peptides are older than vertebrates. The stronger claim is that POMC consolidated multiple peptide outputs into a vertebrate precursor architecture that could coordinate stress, melanocortin, and opioid functions across a larger, more distributed body.
POMC and POMC-derived systems are conserved across vertebrate evolution, though the exact peptides, processing patterns, and tissue distributions vary across lineages. That combination — conserved architecture with local variation — is precisely what makes POMC interesting as a regulatory grammar.
As bodies become more internally differentiated, regulation cannot remain purely local. POMC offers a way to coordinate mobilization, conservation, and recalibration from one precursor family while preserving distinct budgets for each demand. This is why the model treats POMC as the molecular foundation of the affective sphere.